Stockreport

RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF Renowned Clinical Oncology Sites Participating in Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial; Trial Moving Towards Next Interim Analysis and Full Enrollment A [Read more]